Biohaven BHVN Issuance of common shares as payment under license and other agreements
Issuance of common shares as payment under license and other agreements at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept bhvn:ProceedsFromIssuanceOfCommonStockForLicenseAgreements.
The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biohaven's issuance of common shares as payment under license and other agreements.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biohaven's issuance of common shares as payment under license and other agreements?
- Biohaven (BHVN) reported issuance of common shares as payment under license and other agreements of $858K in Q1 2026.
- How has Biohaven's issuance of common shares as payment under license and other agreements changed year-over-year?
- Biohaven's issuance of common shares as payment under license and other agreements decreased by 82.3% year-over-year, from $4.84M to $858K.
- What does issuance of common shares as payment under license and other agreements mean?
- Reflects the non-cash consideration provided to third parties in the form of equity to satisfy obligations under licensing or collaborative development agreements. It serves as an indicator of how the company manages partnership costs while preserving liquidity for core clinical operations.